Risks of cancer among a cohort of 23,935 men and women with osteoporosis

International Journal of Cancer

Volumn 122, Issue 8, 2008, Pages 1879-1884

  McGlynn, Katherine A ^a   Gridley, Gloria ^a   Mellemkjaer, Lene ^b   Brinton, Louise A ^a   Anderson, Kenneth C ^c   Caporaso, Neil E ^a   Landgren, Ola ^a   Olsen, Jorgen H ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Age; Alcohol; Breast cancer; Colorectal cancer; Endometrial cancer; Osteoporosis; Prostate cancer; Smoking

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH CAVITY; OSTEOPOROSIS; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SEX RATIO; AGE; AGED; COHORT ANALYSIS; INCIDENCE; MIDDLE AGED; NEOPLASM; ONSET AGE; POSTMENOPAUSE OSTEOPOROSIS; REGISTER; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

AGE DISTRIBUTION; AGE FACTORS; AGE OF ONSET; AGED; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS;

EID: 40349113326     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23290     Document Type: Article

References (48)

1. Cauley JA, Lucas FL, Kuller LH, Vogt MT, Browner WS, Cummings SR. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 1996;276:1404-8.
2. Ganry O, Peng J, Dubreuil A. Is there a reduced risk of breast cancer among women with hip fractures? Eur J Epidemiol 1999;15:313-15.
3. Newcomb PA, Trentham-Dietz A, Egan KM, Titus-Emstoff L, Baron JA, Storer BE, Willett WC, Stampfer MJ. Fracture history and risk of breast and endometrial cancer. Am J Epidemiol 2001;153:1071-8.
4. Olsson H, Hagglund G. Reduced cancer morbidity and mortality in a prospective cohort of women with distal forearm fractures. Am J Epidemiol 1992;136:422-7.
5. Persson I, Adami HO, McLaughlin JK, Naessen T, Fraumeni JF Jr. Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden). Cancer Causes Control 1994;5:523-8.
6. Persson I, Naessen T, Adami HO, Bergstrom R, Lagrelius A, Mollerstrom G, Pettersson B, von HK. Reduced risk of hip fracture in women with endometrial cancer. Int J Epidemiol 1992;21:636-42.
7. Bunker CH, Zmuda JM, Patrick AL, Wheeler VW, Weissfeld JL, Kuller LH, Cauley JA. High bone density is associated with prostate cancer in older Afro-Caribbean men: tobago prostate survey. Cancer Causes Control 2006;17:1083-9.
8. Zhang Y, Kiel DP, Ellison RC, Schatzkin A, Dorgan JF, Kreger BE, Cupples LA, Felson DT. Bone mass and the risk of prostate cancer: the Framingham Study. Am J Med 2002;113:734-9.
9. Simon LS. Osteoporosis. Rheum Dis Clin North Am 2007;33:149-4.
10. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995;16:87-116.
11. Lane NE Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 2006;194:S3-S11.
12. Riggs BL. Overview of osteoporosis. West J Med 1991;154:63-77.
13. Adami HO, Zack M, Kressner U, Persson I, Berglund A, Naessen T, Bergkvist L. Hip fractures in women with breast cancer. Am J Epidemiol 1990;132:877-83.
14. Utz JP, Melton LJ, III, Kan SH, Riggs BL. Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chronic Dis 1987;40:105-13.
15. Buist DS, LaCroix AZ, Barlow WE, White E, Weiss NS. Bone mineral density and breast cancer risk in postmenopausal women. J Clin Epidemiol 2001;54:417-22.
16. Lucas FL, Cauley JA, Stone RA, Cummings SR, Vogt MT, Weissfeld JL, Kuller LH. Bone mineral density and risk of breast cancer: differences by family history of breast cancer. Study of Osteoporotic Fractures Research Group. Am J Epidemiol 1998;148:22-9.
17. Zhang Y, Kiel DP, Kreger BE, Cupples LA, Ellison RC, Dorgan JF, Schatzkin A, Levy D, Felson DT. Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med 1997;336:611-17.
18. Nguyen TV, Center JR, Eisman JA. Association between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study. Maturitas 2000;36:27-34.
19. Nelson RL, Turyk M, Kim J, Persky V. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2002;2:22.
20. Douchi T, Yamamoto S, Nakamura S, Oki T, Maruta K, Nagata Y. Bone mineral density in postmenopausal women with endometrial cancer. Maturitas 1999;31:165-70.
21. Al-Zoughool M, Dossus L, Kaaks R, Clavel-Chapelon F, Tjonneland A, Olsen A, Overvad K, Boutron-Ruault MC, Gauthier E, Linseisen J, Chang-Claude J, Boeing H, et al. Risk of endometrial cancer in relationship to cigarette smoking: Results from the EPIC study. Int J Cancer 2007;121:2741-7.
22. Terry PD, Rohan TE, Franceschi S, Weiderpass E. Cigarette smoking and the risk of endometrial cancer. Lancet Oncol 2002;3:470-80.
23. Gruntmanis U. Male osteoporosis: deadly, but ignored. Am J Med Sci 2007;333:85-92.
24. Parsons JK, Carter HB, Platz EA, Wright EJ, Landis P, Metter EJ. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy. Cancer Epidemiol Biomarkers Prev 2005;14:2257-60.
25. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121:1571-8.
26. Demark-Wahnefried W, Conaway MR, Robertson CN, Mathias BJ, Anderson EE, Paulson DF. Anthropometric risk factors for prostate cancer. Nutr Cancer 1997;28:302-7.
27. Giovannucci E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 1998;9:567-82.
28. Giovanucci E, Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention, 3rd edn New York: Oxford University Press, 2006. 809-29.
29. Zhang Y, Felson DT, Ellison RC, Kreger BE, Schatzkin A, Dorgan JF, Cupples LA, Levy D, Kiel DP. Bone mass and the risk of colon cancer among postmenopausal women: the Framingham study. Am J Epidemiol 2001;153:31-7.
30. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
31. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
32. London WT, McGlynn KA. Liver cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006. 763-86.
33. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharnyx. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006. 674-96.
34. Blankenstein MA, Verheijen FM, Jacobs JM, Donker TH, van Duijnhoven MW, Thijssen JH. Occurrence, regulation, and significance of progesterone receptors in human meningioma. Steroids 2000;65:795-800.
35. Cantor KP, Lynch CF, Johnson D. Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States). Cancer Causes Control 1993;4:505-11.
36. Kubo M, Fukutomi T, Akashi-Tanaka S, Hasegawa T. Association of breast cancer with meningioma: report of a case and review of the literature. Jpn J Clin Oncol 2001;31:510-13.
37. Melton LJ, III, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV. Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res 2005;20:487-93.
38. Bommert K, Bargou RC, Stuhmer T. Signalling and survival pathways in multiple myeloma. Eur J Cancer 2006;42:1574-80.
39. Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease: pathophysiology of osteoblast inhibition. Blood 2006;108:3992-6.
40. Stewart JP, Shaughnessy JD Jr. Role of osteoblast suppression in multiple myeloma. J Cell Biochem 2006;98:1-13.
41. Chatterjee M, Jain S, Stuhmer T, Andrulis M, Ungethum U, Kuban RJ, Lorentz H, Bommert K, Topp M, Kramer D, Muller-Hermelink HK, Einsele H, et al. STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90α and β in multiple myeloma cells, which critically contribute to tumor-cell survival. Blood 2007;109:720-8.
42. Masih-Khan E, Trudel S, Heise C, Li Z, Paterson J, Nadeem V, Wei E, Roodman D, Claudio JO, Bergsagel PL, Stewart AK. MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma. Blood 2006;108:3465-71.
43. Arbiser JL, Kau T, Konar M, Narra K, Ramchandran R, Summers SA, Vlahos CJ, Ye K, Perry BN, Matter W, Fischl A, Cook J, et al. Solenopsin, the alkaloidal component of the fire ant (Solenopsis invicta), is a naturally occurring inhibitor of phosphatidylinositol-3-kinase signaling and angiogenesis. Blood 2007;109:560-5.
44. Tai YT, Li XF, Breitkreutz I, Song W, Neri P, Catley L, Podar K, Hideshima T, Chauhan D, Raje N, Schlossman R, Richardson P, et al. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res 2006;66:6675-82.
45. Krishnan V, Bryant HU, Macdougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest 2006;116:1202-9.
46. Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006;21:1003-11.
47. Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, et al. FSH directly regulates bone mass. Cell 2006;125:247-60.
48. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12:17-25.